You have 9 free searches left this month | for more free features.

Mitomycin

Showing 1 - 25 of 501

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)

Completed
  • Bladder Cancer
  • intravesical mitomycin-C 40mg/20ml instillation
  • Goyang, Korea, Republic of
    National Cancer Center
Jan 30, 2023

Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)

Not yet recruiting
  • Urothelial Carcinoma Ureter
  • Urothelial Cancer of Renal Pelvis
  • Mitomycin C
  • (no location specified)
Jul 31, 2023

Urothelial Carcinoma Trial in Gainesville (Mitomycin c)

Active, not recruiting
  • Urothelial Carcinoma
  • Mitomycin c
  • Gainesville, Florida
    University of Florida
Dec 6, 2022

Pterygium Trial in Menoufia (Mitomycin c)

Completed
  • Pterygium
  • Mitomycin c
  • Menoufia, Egypt
    Faculty of Medicine, Menoufia University
Nov 16, 2022

Thrombotic Microangiopathy Associated With Mitomycin C, Treated

Recruiting
  • Thrombotic Microangiopathies
    • Strasbourg, France
      Service de Néphrologie, Dialyse et Transplantation - CHU de Stra
    Oct 18, 2023

    Lung Non-Small Cell Carcinoma, Mediastinal Tumor, Pleural Tumor Trial in Duarte (Angiography, Computed Tomography, Ethiodized

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +2 more
    • Angiography
    • +5 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Hepatocellular Carcinoma, Peritoneal Metastasis, Hyperthymic Trial in Chengdu (mitomycin C-based hyperthermic intraperitoneal

    Recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • mitomycin C-based hyperthermic intraperitoneal chemotherapy
    • Chengdu, Sichuan, China
      West China Hospital
    Sep 14, 2022

    Myopia Trial in Damieta (Transepithelial PRK/MMC, Alcohol-Assisted PRK/MMC)

    Recruiting
    • Myopia
    • Transepithelial PRK/MMC
    • Alcohol-Assisted PRK/MMC
    • Damieta, New Damietta, Egypt
      Ehab tharwat
    Sep 17, 2022

    Presbyopia Trial in Bloomington, Dallas, San Antonio (Mitomycin c, Raindrop Near Vision Inlay)

    Terminated
    • Presbyopia
    • Mitomycin c
    • Raindrop Near Vision Inlay
    • Bloomington, Minnesota
    • +2 more
    Aug 15, 2022

    Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Squamous Cell Carcinoma, Head and Neck
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 21, 2022

    Esophageal Stenosis, Anastomotic Stenosis Trial in Philadelphia (Mitomycin C, Control)

    Withdrawn
    • Esophageal Stenosis
    • Anastomotic Stenosis
    • Mitomycin C
    • Control
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Apr 1, 2022

    Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial

    Available
    • Urothelial Cancer of Renal Pelvis
    • +5 more
    • Mitomycin for pyelocalyceal solution
    • (no location specified)
    Aug 5, 2022

    Bladder Cancer Trial in Aarhus (Mitomycin c)

    Active, not recruiting
    • Bladder Cancer
    • Mitomycin c
    • Aarhus, Denmark
      Aarhus University Hospital
    Aug 5, 2022

    Glaucoma, Open-Angle Trial in Oakville (XEN 63)

    Recruiting
    • Glaucoma, Open-Angle
    • XEN 63
    • Oakville, Ontario, Canada
      Prism Eye Institute
    Sep 26, 2022

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,

    Active, not recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 12, 2022

    Glaucoma, Primary Open Angle Glaucoma, Secondary Glaucoma Trial in Worldwide (drug, other, procedure)

    Completed
    • Glaucoma
    • +3 more
    • San Francisco, California
    • +3 more
    May 27, 2022

    Diseases of Oesophagus Stomach and Duodenum Trial in Houston (Dexamethasone, Diphenhydramine, Famotidine)

    Active, not recruiting
    • Diseases of Oesophagus Stomach and Duodenum
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 7, 2022

    Colorectal Cancer, Chemo Effect, Surgery Trial (Mitomycin, Lobaplatin)

    Not yet recruiting
    • Colorectal Cancer
    • +4 more
    • (no location specified)
    Feb 18, 2022

    Locally Advanced Anal Canal Cancer Trial in France (5Fluorouracile and Mitomycin-C, Simultaneously integrated boost of intensity

    Active, not recruiting
    • Locally Advanced Anal Canal Cancer
    • 5Fluorouracile and Mitomycin-C
    • Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
    • Angers, France
    • +7 more
    Dec 7, 2022

    Lower Urinary Tract Symptoms After Intravesical Therapy

    Recruiting
    • Chemotherapy Effect
    • +3 more
    • Validated questionnaires
    • Munich, Bavaria, Germany
      Nikolaos Pyrgidis
    May 3, 2023

    Severe Neutropenia After HIPEC Using Mitomycin-C

    Recruiting
    • Colorectal Cancer Metastatic
    • +3 more
    • Intraoperative blood and peritoneal fluid samplings during HIPEC
    • Seoul, Korea, Republic of
      Division of Colon and Rectal Surgery, Department of Surgery, Gan
    Aug 21, 2022

    Upper Urinary Tract Carcinoma Trial

    Not yet recruiting
    • Upper Urinary Tract Carcinoma
      • (no location specified)
      Feb 7, 2023

      Corneal Opacity Trial in San Diego (Mitomycin-C, Fluorometholone 1% topical ocular steroid)

      Active, not recruiting
      • Corneal Opacity
      • San Diego, California
        Navy Warfighter Refractive Surgery Center
      Apr 14, 2022

      Punctal Stenosis Trial in Damieta (3-snip punctoplasty, 3-snip punctoplasty and Mitomycin C)

      Completed
      • Punctal Stenosis
      • 3-snip punctoplasty
      • 3-snip punctoplasty and Mitomycin C
      • Damieta, New Damietta, Egypt
        Ehab tharwat
      Oct 15, 2022

      Peritoneal Carcinomatosis Trial in Lexington (Mitomycin C, flat dose 40 mg, Mitomycin C, weight-based dose 12.5 mg/m2)

      Recruiting
      • Peritoneal Carcinomatosis
      • Mitomycin C, flat dose 40 mg
      • Mitomycin C, weight-based dose 12.5 mg/m2
      • Lexington, Kentucky
        University of Kentucky
      Mar 1, 2022